Etiological Principle of Therapy
Goal: Complete elimination of the genetic cause of the disease and associated risk factors.
Main method: Gene therapy. It involves the targeted correction of identified genetic defects at the DNA level. Today, this field is considered the most promising; however, most techniques are still in the stages of laboratory development, clinical evaluation, or are only partially applied in medical practice.
Pathogenetic Principle of Therapy
Goal: To interrupt the mechanisms of disease development (breaking the links of pathogenesis) triggered by a mutation. This approach is implemented through three main strategies:
- Replacement therapy. The patient is artificially administered a substance that the body cannot synthesize independently due to a gene defect.
- Examples: Regular insulin injections in diabetes mellitus, administration of specific enzymes in glycogen storage diseases, and the use of antihemophilic globulin in hemophilia.
- Metabolic correction. Allows for the mitigation of biochemical disruptions in three ways:
- Restricting the intake of substances that are metabolically unabsorbable (strict diet excluding phenylalanine or lactose).
- Stimulating the excretion of metabolites that accumulate in excess in the body (accelerated elimination of cholesterol or phenylpyruvic acid).
- Regulating enzyme activity (suppressing creatine phosphokinase activity in certain myopathies or activating blood lipoprotein lipase in hypercholesterolemia).
- Surgical correction of defects. Surgical intervention to compensate for metabolic disturbances.
- Example: Formation of a portosystemic shunt between the inferior vena cava and the portal vein in patients with hepatogenic glycogen storage diseases.
Symptomatic Therapy
Goal: Relief of disease manifestations that worsen the patient's condition. This approach does not eliminate the genetic cause of the pathology, but it is critically important for alleviating symptoms and improving quality of life.
Examples of clinical application:
- Cystic fibrosis: Administration of specialized drugs (mucolytics) that effectively reduce the viscosity of thick exocrine gland secretions.
- Limb malformations: In polydactyly or syndactyly, surgeons remove extra digits or divide skin webs between them.
- Congenital defects: Performing reconstructive plastic surgeries for anatomical facial defects, as well as complex surgical correction of congenital heart and vascular defects.
Preventive Direction of Medical Genetics
Goal: To prevent the birth of affected children or minimize the risk of manifestation of diseases whose etiology is driven by genomic alterations.
Preventive measures are strictly targeted at three categories of genome alterations:
- Mutations occurring directly in the parents' germ cells (gametes).
- Pathological changes inherited from previous generations (familial loading).
- Changes that manifest against the background of a genetic predisposition under the triggering influence of adverse environmental factors.